express gazette logo
The Express Gazette
Saturday, May 9, 2026

Doctors Downplay Fear Around 'Razor Blade' Sore Throat Reports Amid COVID Spread

Search interest rose after reports from China, but clinicians say intense throat pain has been reported with COVID before and is not yet evidence of a new symptom or variant

Health 8 months ago
Doctors Downplay Fear Around 'Razor Blade' Sore Throat Reports Amid COVID Spread

Reports of an extraordinarily painful sore throat being described online as a "razor blade" throat have drawn attention in recent days after accounts emerged from China and related search queries spiked in the United States. Public interest, measured by Google Trends and social media chatter, has prompted questions about whether a new COVID-19 variant is producing a previously unseen symptom.

Infectious disease specialists and public health clinicians say the reports are not unexpected but should not prompt panic. Severe throat pain has been documented with respiratory viruses, including prior waves of COVID-19, and experts say anecdotal reports often surface when a region is experiencing a rise in cases.

"When new variants have come on the scene in the past, there almost invariably have been questions about distinctive symptoms, and after a while, when you gather a lot of data, it turns out not to be the case — all of these symptoms have occurred before," said Dr. William Schaffner, a professor of preventive medicine, noting that clinicians track symptom patterns closely as variants spread.

Health authorities list a range of common COVID-19 symptoms, including fever, cough, fatigue, congestion and sore throat. Clinicians say the intensity of those symptoms can vary widely from person to person. A particularly painful sore throat can occur with COVID-19 as well as with other viral and bacterial infections such as strep throat, experts said.

Public-health surveillance and clinical data, rather than individual anecdotes, are needed to establish whether a change in symptom profile represents a genuine shift tied to a new variant. Epidemiologists review clinical reports, laboratory sequencing, and pooled symptom data to determine whether patterns are emerging that warrant revised guidance.

In the meantime, clinicians recommend standard measures for anyone experiencing an acute sore throat or other respiratory symptoms: test for COVID-19 if testing is available, isolate while infectious or awaiting results, and seek medical care if symptoms worsen. Over-the-counter pain relievers, throat lozenges, warm fluids and rest can help manage pain for many patients. Medical evaluation is advised when patients have difficulty breathing, cannot swallow liquids, exhibit signs of dehydration, or experience persistent high fever.

Vaccination and up-to-date boosters reduce the risk of severe illness, hospitalization and death from COVID-19, public-health officials say, even as breakthrough infections continue to occur. Those at higher risk because of age or underlying conditions should maintain communication with their health care providers about prevention and treatment options, including antiviral medications when clinically appropriate.

As with prior periods of heightened attention to symptoms, clinicians urge reliance on verified clinical data and guidance from public-health authorities rather than social media reports alone. Health agencies and researchers will continue to monitor case reports and sequencing data to identify any meaningful changes in the virus or its clinical presentation.


Sources